Effect of neoadjuvant therapy on breast cancer biomarker profile | BMC Cancer | Full Text

Effect of neoadjuvant therapy on breast cancer biomarker profile | BMC Cancer | Full Text

Effect of neoadjuvant therapy on breast cancer biomarker profile

Breast cancer clinical management requires the assessment of hormone receptors (estrogen (ER) and progesterone receptor (PR)), human epidermal growth factor receptor 2 (HER2) and cellular proliferation index K...

Authors:Laura Rey-Vargas, Juan Carlos Mejía-Henao, María Carolina Sanabria-Salas and Silvia J. Serrano-Gomez

Citation:BMC Cancer 2020 20:675

Content type:Research article

 

Published on: 18 July 2020

• ViewFull Text
 
• ViewPDF